Drugmakers must face skincare drug price-fixing lawsuit, US judge rules

Core Point - A federal judge has ruled that 36 drugmakers and executives must confront nearly all claims in an antitrust lawsuit regarding price-fixing of 80 generic drugs [1] Group 1 - The lawsuit has been initiated by most U.S. states, indicating a significant legal challenge for the pharmaceutical industry [1]